We believe that authors should retain the copyright of their research manuscripts and receive clear credit for their work.

Pharma Research Library (PRL)committed to protecting our authors against infringement of intellectual property, while also considering the sensitivities and concerns of the research community. We achieve this by proactively identifying, monitoring, and taking action against potential instances of infringement to ensure that any threats to the intellectual property rights of our authors are targeted, disrupted, and, where possible, closed down.

Open Access Articles

Authors retain the copyright of all open access articles published by Pharma Research Library (PRL). Authors publishing their articles open access will sign an open access License to Publish Agreement (LTP) and grant non-exclusive rights to Pharma Research Library (PRL)Journals where Creative Commons Attribution-Non Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0) license is selected, or exclusive non commercial rights where CC BY-NC is chosen.

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. CC BY-NC includes the following elements

BY: credit must be given to the creator.
NC: Only noncommercial uses of the work are permitted.

Subscription Articles

The Pharma Research Library (PRL)do not require authors to transfer the copyright of their published contributions.In addition to the use cases described in the Rights for Reuse table above, authors also have additional rights to make use of their articles. Unless otherwise specified, these use cases refer to the reuse of the published version of the record, in whole or in part.